Cargando…
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
INTRODUCTION: Hospitals are increasingly forced to consider the economics of technology use. We estimated the incremental cost-consequences of remifentanil-based analgo-sedation (RS) vs. conventional analgesia and sedation (CS) in patients requiring mechanical ventilation (MV) in the intensive care...
Autores principales: | Al, Maiwenn J, Hakkaart, Leona, Tan, Siok Swan, Bakker, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219979/ https://www.ncbi.nlm.nih.gov/pubmed/21040558 http://dx.doi.org/10.1186/cc9313 |
Ejemplares similares
-
Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
por: Al, M, et al.
Publicado: (2007) -
Remifentanil for postoperative analgo-sedation: effects on glycaemia and HOMA score
por: Chelazzi, C, et al.
Publicado: (2010) -
Weaning from mechanical ventilation using remifentanil versus midazolam–morphine analgo sedation: our experience
por: Nardo, M Di, et al.
Publicado: (2005) -
Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients
por: Van den Bosch, J, et al.
Publicado: (2011) -
Consensus Statement on Analgo-sedation in Neurocritical Care and Review of Literature
por: Prabhakar, Hemanshu, et al.
Publicado: (2021)